PharmX Technologies Gestione

Gestione criteri di controllo 3/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Tom Culver

Amministratore delegato

AU$219.3k

Compenso totale

Percentuale dello stipendio del CEO	87.3%
Mandato del CEO	less than a year
Proprietà del CEO	n/a
Durata media del management	3.3yrs
Durata media del Consiglio di amministrazione	4.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Tom Culver rispetto agli utili di PharmX Technologies?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	AU$219k	AU$191k	AU$95k

Compensazione vs Mercato: La retribuzione totale di Tom ($USD 142.51K ) è inferiore alla media delle aziende di dimensioni simili nel mercato Australian ($USD 297.98K ).

Compensazione vs guadagni: Dati insufficienti per confrontare la retribuzione di Tom con le performance aziendali.

AMMINISTRATORE DELEGATO

Tom Culver

less than a year

Mandato

AU$219,292

Compensazione

Mr. Tom Culver serves as Head of Wealth & Crypto Services at Douugh Limited since January 2021. Mr. Culver is Goodments Founder & CEO. Mr. Culver is Chief Executive Officer of PharmX Technologies Limited f...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Tom Culver	Chief Executive Officer	less than a year	AU$219.29k	Nessun dato
Zoe Hillier	Chief Financial Officer	3.3yrs	AU$276.23k	0.10% A$ 43.1k
James Nevile	Chief Operating Officer	3.3yrs	AU$310.49k	0% A$ 0
Sally McDow	Company Secretary	no data	Nessun dato	Nessun dato

3.3yrs

Durata media

Gestione esperta: Il team dirigenziale di PHX è considerato esperto (durata media dell'incarico 3.3 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Jayne Shaw	Independent Non-Executive Director	4.1yrs	AU$97.68k	0.46% A$ 191.9k
Andrew Jonathan Newbery	Non-Executive Director	4.8yrs	AU$185.37k	0.29% A$ 118.2k
Philip England	Non-Executive Chairman	5yrs	AU$324.28k	4.51% A$ 1.9m
Alexander Mellis	Non-Executive Independent Director	less than a year	Nessun dato	Nessun dato

4.4yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PHX sono considerati esperti (durata media dell'incarico 4.4 anni).

PharmX Technologies Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

PharmX Technologies Limited, Annual General Meeting, Nov 26, 2024

PharmX Technologies Limited Appoints Alexander Mellis as A Non-Executive and Independent Alternate Director

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

PharmX Technologies Limited Announces the Appointment of Tom Culver as Chief Executive Officer, Effective 20 November 2023

Recent updates

PharmX Technologies Limited, Annual General Meeting, Nov 26, 2024

PharmX Technologies Limited Appoints Alexander Mellis as A Non-Executive and Independent Alternate Director

Full year 2024 earnings released: EPS: AU$0 (vs AU$0.001 loss in FY 2023)

PharmX Technologies Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

Less than half of directors are independent

Less than half of directors are independent

First half 2024 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2023)

PharmX Technologies Limited to Report First Half, 2024 Results on Feb 23, 2024

New major risk - Market cap size

Less than half of directors are independent

PharmX Technologies Limited Announces the Appointment of Tom Culver as Chief Executive Officer, Effective 20 November 2023

PharmX Technologies Limited Announces the Appointment of Tom Culver as Chief Executive Officer, Effective 20 November 2023

PharmX Technologies Limited, Annual General Meeting, Nov 21, 2023

No independent directors

New major risk - Revenue and earnings growth

Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0 in FY 2022)

Corum Group Limited to Report Fiscal Year 2023 Results on Aug 23, 2023

No independent directors

Jonas Software AUS Pty Ltd entered into an agreement to acquire Corum Health Pty Ltd and Amfac Pty Ltd. from Corum Group Limited (ASX:COO) for AUD 6.3 million.

Now 20% undervalued

No independent directors

No independent directors

No independent directors

No independent directors

No independent directors

No independent directors

Corum Group Limited, Annual General Meeting, Nov 14, 2022

Full year 2022 earnings released: EPS: AU$0 (vs AU$0.002 in FY 2021)

No independent directors

Corum Group Limited Launches Pharmxchange Platform

No independent directors

No independent directors

No independent directors

Zenith Payments Pty Ltd completed the acquisition Real Estate eCommerce business unit of Corum Group Limited from Corum Group Limited (ASX:COO).

No independent directors

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Corum Group Limited to Report First Half, 2022 Results on Feb 10, 2022

Corum Group Limited Announces Resignation of Julian Sallabank as Managing Director

Zenith Payments Pty Ltd agreed to acquire Real Estate eCommerce business unit of Corum Group Limited from Corum Group Limited (ASX:COO) for AUD 0.5 million.

No independent directors

Full year 2021 earnings released: EPS AU$0.002 (vs AU$0.001 in FY 2020)

First half 2021 earnings released: EPS AU$0.002 (vs AU$0.001 loss in 1H 2020)

Corum Group Limited to Report First Half, 2021 Results on Feb 24, 2021

Corum Group Limited Announces Appointment of Dennis Bastas to the Board of Directors

Corum Group Limited Appoints Eryl Baron as Company Secretary, Effective 3 November 2020

Corum Group Limited Appoints Jayne Shaw to its Board of Directors

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media